CYCADS* Macrozamin was shown by Cooper (1940) to be the toxic principle of Macroxamia spiralis Miq., a New South Wales cycad. It was later obtained from the Western Australian M. reidlei C. A. Gard. (Lythgoe and Riggs 1949) and shown to be I or I1 (Langley, Lythgoe, and Riggs 1951).
The seeds of Lupinus varius L.
(Leguminosae), used in parts of Western Australia as sheep fodder, contain an
alkaloid LV-1, C15H22ON2 (0.20 per cent.),
(+)-epilupinine (0.13 per cent.), (+)-epilupinine-N-oxide (0.94 per cent.), and
traces of an alkaloid LV-2. The N-oxide represents the first reported natural
occurrence of such a compound in the lupinine group.
Each of the species named in the title has
yielded (+)-usnic acid, as found in previous investigations in other parts of
the world. Other aromatic constituents isolated, except salazinic acid from
Parmelia conspersa differ from those previously reported and include a new
compound from P. conspersa. It is suggested that usnaric acid, previously
obtained from Usnea spp. but unidentified, was a mixture of salazinic and
norstictic acids.
D-Mannitol or D-arabitol has been isolated
from the water-soluble fractions.
Definite increases in rate of reaction
between aryliodoso acetates and N-arylacetamides occur when electron-releasing
groups are introduced into the N-arylacetamide nucleus, the Arrhenius A and E
parameters decreasing simultaneously; electron-attracting substituents cause
the reverse effects. Small, erratic changes in rate and the Arrhenius
parameters accompany substitution in the aryliodoso nucleus. N-Methylation of
aceto-p-toluidide inhibits the reaction completely. Possible mechanisms are
briefly discussed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.